AU2007217630A1 - Dendritic cells transiently transfected with a membrane homing polypeptide and their use - Google Patents

Dendritic cells transiently transfected with a membrane homing polypeptide and their use Download PDF

Info

Publication number
AU2007217630A1
AU2007217630A1 AU2007217630A AU2007217630A AU2007217630A1 AU 2007217630 A1 AU2007217630 A1 AU 2007217630A1 AU 2007217630 A AU2007217630 A AU 2007217630A AU 2007217630 A AU2007217630 A AU 2007217630A AU 2007217630 A1 AU2007217630 A1 AU 2007217630A1
Authority
AU
Australia
Prior art keywords
cells
dcs
antigen
cell
selectin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007217630A
Other languages
English (en)
Other versions
AU2007217630A8 (en
Inventor
Jan Dorrie
Niels Schaft
Gerold Schuler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Friedrich Alexander Universitaet Erlangen Nuernberg
Original Assignee
Merix Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP20060110306 external-priority patent/EP1825859A1/en
Application filed by Merix Bioscience Inc filed Critical Merix Bioscience Inc
Publication of AU2007217630A1 publication Critical patent/AU2007217630A1/en
Publication of AU2007217630A8 publication Critical patent/AU2007217630A8/en
Assigned to KYOWA HAKKO KOGYO CO., LTD., ARGOS THERAPEUTICS, INC. reassignment KYOWA HAKKO KOGYO CO., LTD. Request for Assignment Assignors: ARGOS THERAPEUTICS, INC., KIRIN PHARMA KABUSHIKI KAISHA
Assigned to FRIEDRICH-ALEXANDER-UNIVERSITAT ERLANGEN-NURNBERG reassignment FRIEDRICH-ALEXANDER-UNIVERSITAT ERLANGEN-NURNBERG Request for Assignment Assignors: ARGOS THERAPEUTICS, INC., KYOWA HAKKO KIRIN CO., LTD.
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/19—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4254—Adhesion molecules, e.g. NRCAM, EpCAM or cadherins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4271—Melanoma antigens
    • A61K40/4272—Melan-A/MART
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2007217630A 2006-02-22 2007-02-14 Dendritic cells transiently transfected with a membrane homing polypeptide and their use Abandoned AU2007217630A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US77573506P 2006-02-22 2006-02-22
EP20060110306 EP1825859A1 (en) 2006-02-22 2006-02-22 Dendritic cells transiently transfected with a membrane homing polypeptide and their use
US60/775,735 2006-02-22
EP06110306.5 2006-02-22
PCT/EP2007/051417 WO2007096278A1 (en) 2006-02-22 2007-02-14 Dendritic cells transiently transfected with a membrane homing polypeptide and their use

Publications (2)

Publication Number Publication Date
AU2007217630A1 true AU2007217630A1 (en) 2007-08-30
AU2007217630A8 AU2007217630A8 (en) 2010-04-15

Family

ID=37944318

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007217630A Abandoned AU2007217630A1 (en) 2006-02-22 2007-02-14 Dendritic cells transiently transfected with a membrane homing polypeptide and their use

Country Status (7)

Country Link
US (1) US20090274669A1 (enExample)
EP (1) EP1986667A1 (enExample)
JP (1) JP2009532019A (enExample)
KR (1) KR20080106193A (enExample)
AU (1) AU2007217630A1 (enExample)
CA (1) CA2642999A1 (enExample)
WO (1) WO2007096278A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2072618A1 (en) * 2007-12-14 2009-06-24 Johannes Gutenberg-Universität Mainz Use of RNA for reprogramming somatic cells
WO2009108341A1 (en) 2008-02-28 2009-09-03 Argos Therapeutics, Inc. Transient expression of immunomodulatory polypeptides for the prevention and treatment of autoimmune disease, allergy and transplant rejection
EP2281579A1 (en) 2009-08-05 2011-02-09 BioNTech AG Vaccine composition comprising 5'-Cap modified RNA
WO2015127190A1 (en) * 2014-02-21 2015-08-27 Argos Therapeutics, Inc. Tscm cells and methods for use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000060055A1 (en) * 1999-04-01 2000-10-12 The Brigham And Women's Hospital, Inc. Modified dendritic cells and uses therefor
US6929792B1 (en) * 1999-04-01 2005-08-16 The Brigham & Women's Hospital, Inc. Modified dendritic cells and use therefor
US7547551B2 (en) * 2001-06-21 2009-06-16 University Of Antwerp. Transfection of eukaryontic cells with linear polynucleotides by electroporation

Also Published As

Publication number Publication date
KR20080106193A (ko) 2008-12-04
US20090274669A1 (en) 2009-11-05
EP1986667A1 (en) 2008-11-05
CA2642999A1 (en) 2007-08-30
JP2009532019A (ja) 2009-09-10
WO2007096278A1 (en) 2007-08-30
AU2007217630A8 (en) 2010-04-15

Similar Documents

Publication Publication Date Title
CA2577125C (en) Mature dendritic cell compositions and methods for culturing same
EP0922758B1 (en) Methods and compositions for obtaining mature dendritic cells
US7198948B2 (en) Methods and compositions for obtaining mature dendritic cells
JP7604000B2 (ja) 改変ヒト初代血液樹状細胞株を生成するための方法
US20090226404A1 (en) Methods for Generating Antigen-Specific Effector T Cells
JP2021514665A (ja) がんおよび感染症を処置するための治療用細胞系および方法
JP2011504101A5 (enExample)
AU2007235227A1 (en) Mature dendritic cell compositions and methods for culturing same
ES2234928T3 (es) Generacion y uso de celulas dendriticas.
JP2018531022A6 (ja) 改変ヒト初代血液樹状細胞株を生成するための方法
Byrne et al. Dendritic cells: making progress with tumour regression?
US20090274669A1 (en) Dendritic Cells Transiently Transfected with a Membrane Homing Polypeptide and their use
JP2025541604A (ja) リンパ球の拡大
EP1825859A1 (en) Dendritic cells transiently transfected with a membrane homing polypeptide and their use
EP0941309A1 (en) Cellular adjuvant
WO2012101109A1 (en) Native dendritic cells
Salem et al. Higher Activities of Hepatic Versus Splenic CD8+ T Cells in Responses to Adoptive T Cell Therapy and Vaccination of B6 Mice with MHC Class-1 Binding Antigen
HK1128489A (en) Methods for generating antigen-specific effector t cells
HK1105997B (en) Mature dendritic cell compositions and methods for culturing same
AU5041598A (en) Cellular adjuvant

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 22, NO 38, PAGE(S) 4512 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME ARGOS THERAPEUTICS, INC., APPLICATION NO. 2007217630, UNDER INID (71) ADD CO-APPLICANT KIRIN PHARMA KABUSHIKI KAISHA

PC1 Assignment before grant (sect. 113)

Owner name: KYOWA HAKKO KOGYO CO., LTD.; ARGOS THERAPEUTICS, I

Free format text: FORMER APPLICANT(S): ARGOS THERAPEUTICS, INC.; KIRIN PHARMA KABUSHIKI KAISHA

PC1 Assignment before grant (sect. 113)

Owner name: FRIEDRICH-ALEXANDER-UNIVERSITAT ERLANGEN-NURNBERG

Free format text: FORMER APPLICANT(S): ARGOS THERAPEUTICS, INC.; KYOWA HAKKO KIRIN CO., LTD.

MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application